Exercise-conditioned extracellular vesicles in Alzheimer’s disease: a multi-organ signaling network linking peripheral adaptation to brain pathology

• by Rui Zhang, Kang Chen

• July 2, 2026

LC–MS-based serum metabolomics reveals distinct metabolic signatures in patients with intracerebral Hemorrhage

• by Wei Zheng, Wei Wang, Xiaohui Lu

• July 2, 2026

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study

• by Isabell Brikell, Aske Astrup, Theresa Wimberley, Masako Araki, Zheng Chang, Ditte Demontis, Zihan Dong, Stephen V Faraone, Le Gao, Malcolm B Gillies, Jan Haavik, Catharina Hartman, Henrik Larsson, Kenneth K C Man, Sallie-Anne Pearson, Harold Snieder, Melissa Vos, Ian C K Wong, Honghui Yao, Andrew SC Yuen, Yanli Zhang-James, Yiling Zhou, Helga Zoega, Anders Engeland, Søren Dalsgaard, Kari Klungsøyr

• July 2, 2026

ASCO26: David Reardon, MD, Glioblastoma Vaccine

Dana-Farber Cancer Institute's Dr. David Reardon reports on data showing a phase 1 trial looking at a personalized vaccine plus pembrolizumab sparked tumor-targeting T cells in glioblastoma and was linked to longer survival in immune responders.

• July 1, 2026

• 1 min